Skip to content
Research Article Open access CC BY 4.0

Evaluation of Non-response to Hepatitis B Vaccines in Individuals Over 15 Years in the Centre Region of Cameroon: A Cross-sectional Study

Justin Olivier Essindi, Jacky Njiki Bikoï, Carole Stéphanie Sake, Donatien Serge Mbaga, Arnaud Franck Elang, Chris André Mbongue Mikangue, Aicha Ngoutane, Alexandra Emmanuelle Membangbi, Sabine Aimée Touangnou-Chamda, Sara Honorine Riwom Essama

Microbiology Research Journal International · pp. 36–44 · Published 2 Mar 2024

10.9734/mrji/2024/v34i11424

Abstract

Background: To investigate the risks factors associated to the non-response of hepatitis B (HB) immunization in participants over the age of 15 years. Methods: From October 2020 to December 2021, data were collected from individuals aged over 15 years who receive at least one dose of vaccine. An algorithm consisted of three (03) tests researching anti-HBs whose detectability threshold was 10 IU/L and anti-HBc. Results: A total of 330 participants were included in this study, among which 158 received three doses of vaccine, of these 83.59% and 6,6% were found positive respectively to anti HBs and anti-HBc. We noted that, age [30 – 40] years [OR= 2.41; CI at 95% (1.24 – 4.80)]; single status [OR=10.80; CI at 95% (1.78 – 114.8)], obesity [OR=2.99; CI at 95% (1.13 – 7.27)], alcohol [OR=10.80; CI at 95% (1.78 – 114.8)]; HEPATITIS vaccine [OR=3.40; CI at 95% (1.24 – 9.10)] were associated with non-response to hepatitis B vaccines. Conclusion: Non-response to hepatitis B vaccination has been influenced by several risk factors that should be considered during the vaccination process.

Anti-HBc anti-HBs hepatitis B vaccines

References (23)

  1. 1 The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies [DOI]
  2. 2 The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies [DOI]
  3. 3 Factors That Influence the Immune Response to Vaccination [DOI]
  4. 4 Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination [DOI]
  5. 5 Seroprevalence of hepatitis B virus infection in Cameroon: a systematic review and meta-analysis [DOI]
  6. 6 Hepatitis B vaccine development and implementation [DOI]
  7. 7 Protection Provided by Hepatitis B Vaccine in a Yupik Eskimo Population--Results of a 10-Year Study [DOI]
  8. 8 Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: Implications in hepatitis B vaccination programs [DOI]
  9. 9 Epidemiology of hepatitis B and the role of vaccination [DOI]
  10. 10 Hepatitis B infection among health workers in Uganda: Evidence of the need for health worker protection [DOI]
  11. 11 Long-term immune protection against HBV: associated factors and determinants [DOI]
  12. 12 Effects of Risk Factors on Anti-HBs Development in Hepatitis B Vaccinated and Nonvaccinated Populations [DOI]
  13. 13 Long-term persistency of hepatitis B immunity: an observational cross-sectional study on medical students and resident doctors [DOI]
  14. 14 Future Healthcare Workers and Hepatitis B Vaccination: A New Generation [DOI]
  15. 15 Factors influencing long-term persistence of anti-HBs after hepatitis B vaccination [DOI]
  16. 16 Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents [DOI]
  17. 17 Predictors of Hepatitis B Surface Antigen Titers two decades after vaccination in a cohort of students and post-graduates of the Medical School at the University of Palermo, Italy [DOI]
  18. 18 Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study [DOI]
  19. 19 An experience of hepatitis B control in a rural area in Far North Cameroon [DOI]
  20. 20 Low Viral Load Does Not Exclude Significant Liver Damage in Patients with Chronic HBV Infection in Bangladesh [DOI]
  21. 21 Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents [DOI]
  22. 22 Response to deltoid muscle injection of hepatitis B vaccine after failure to respond to gluteal injections [DOI]
  23. 23 Response to deltoid muscle injection of hepatitis B vaccine after failure to respond to gluteal injections.

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

55

Page views

0

PDF downloads

22

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.